Conference Coverage

Be alert for BAP1 mutations in hereditary melanomas


 

REPORTING FROM ODAC 2018

Follow-up and genetic counseling

There is no standard protocol for follow-up once a patient is identified with a BAP1 mutation. “I refer them for uveal, kidney, and/or lung cancer evaluation and see them back two to four times a year for skin checks.”

Another attendee asked about genetic counseling. “I encourage genetic counseling since dermatologists often don’t have time to take at detailed family history of all cancers and ages of onset,” Dr. Tsao said. “Genetic counselors can help sort out the strength of the genetic pedigree in a family. My residents usually ask if someone has a history of melanoma in their family, and that’s it. But there is a big difference between having a cousin with melanoma and three brothers with melanoma.”

Pages

Recommended Reading

T-VEC improves melanoma response without toxicity increase
MDedge Hematology and Oncology
Neoantigen profiling predicts response to immunotherapy
MDedge Hematology and Oncology
Gut bacteria influenced response to checkpoint inhibitors
MDedge Hematology and Oncology
Breakthrough cancer gene assay approved, CMS proposes coverage
MDedge Hematology and Oncology
First-in-class glutaminase inhibitor combats anti-PD-1/PD-L1 resistance
MDedge Hematology and Oncology
Metastatic eccrine carcinoma with stomach and pericardial involvement
MDedge Hematology and Oncology
FDA expands approval of nivolumab for melanoma treatment
MDedge Hematology and Oncology
Desmoplastic melanoma yields to checkpoint inhibitors
MDedge Hematology and Oncology
Supportive oncodermatology: Cancer advances spawn new subspecialty
MDedge Hematology and Oncology
Neoadjuvant dabrafenib and trametinib improves event-free survival in resectable melanoma
MDedge Hematology and Oncology